Trial · NCT02672852
Participant flow63
How many started, completed or left each group, period by period.
1 to 20 of 63
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part A1 | STARTED | Placebo (Part A1) | 100 | |
| Part A1 | STARTED | Risankizumab (Part A1) | 407 | |
| Part A1 | STARTED | Placebo/Risankizumab Part A2/Part B | 0 | |
| Part A1 | STARTED | Risankizumab/Risankizumab Part A2 | 0 | |
| Part A1 | STARTED | Risankizumab/Placebo (Part B; Rerandomized Responders) | 0 | |
| Part A1 | STARTED | Risankizumab/Risankizumab (Part B; Rerandomized Responders) | 0 | |
| Part A1 | STARTED | Risankizumab/Risankizumab Part B (Nonresponders) | 0 | |
| Part A1 | COMPLETED | Placebo (Part A1) | 97 | |
| Part A1 | COMPLETED | Risankizumab (Part A1) | 403 | |
| Part A1 | COMPLETED | Placebo/Risankizumab Part A2/Part B | 0 | |
| Part A1 | COMPLETED | Risankizumab/Risankizumab Part A2 | 0 | |
| Part A1 | COMPLETED | Risankizumab/Placebo (Part B; Rerandomized Responders) | 0 | |
| Part A1 | COMPLETED | Risankizumab/Risankizumab (Part B; Rerandomized Responders) | 0 | |
| Part A1 | COMPLETED | Risankizumab/Risankizumab Part B (Nonresponders) | 0 | |
| Part A1 | NOT COMPLETED | Placebo (Part A1) | 3 | |
| Part A1 | NOT COMPLETED | Risankizumab (Part A1) | 4 | |
| Part A1 | NOT COMPLETED | Placebo/Risankizumab Part A2/Part B | 0 | |
| Part A1 | NOT COMPLETED | Risankizumab/Risankizumab Part A2 | 0 | |
| Part A1 | NOT COMPLETED | Risankizumab/Placebo (Part B; Rerandomized Responders) | 0 | |
| Part A1 | NOT COMPLETED | Risankizumab/Risankizumab (Part B; Rerandomized Responders) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02672852/flow